The breadth of applications will widen as the number of new platforms grows, according Joshua Calvert, MD, MPH.

Robotics in GU oncology: Current status, future directions

Advances in genomic testing will help determine lines of therapy in men with mCSPC and mCRPC, according to Raoul S. Concepcion, MD.

Role and rationale for molecular testing in advanced prostate cancer

Systemic and intravesical therapies are changing the landscape of BCG-unresponsive disease, according to Matthew Galsky, MD.